Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis

Company Overview

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.

Key Stats

• Today's Range: $0.0075 to $0.0075
• 50-Day Range: $0.0066 to $0.0118
• 52-Week Range: $0.0044 to $0.0178
• Volume: 1 shs
• Average Volume: 13,204 shs
• Market Capitalization: $2.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AOXG Stock Analysis - Frequently Asked Questions

How have AOXG shares performed this year?

Aoxing Pharmaceutical's stock was trading at $0.0071 at the beginning of 2025. Since then, AOXG shares have increased by 5.6% and is now trading at $0.0075.
View the best growth stocks for 2025 here.

How were Aoxing Pharmaceutical's earnings last quarter?

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) issued its earnings results on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $6.56 million for the quarter.

How do I buy shares of Aoxing Pharmaceutical?

Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aoxing Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC) and Edap Tms (EDAP).

Company Calendar

• Last Earnings: 5/16/2016
• Today: 6/27/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AOXG
• Previous Symbol: NYSEMKT:AXN
• CIK: N/A
• Web: axzyen.icm.cn
• Phone: (646) 367-1747
• Fax: 646-367-1747
• Employees: 350
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 381,210,000
• Free Float: 313,354,000
• Market Cap: $2.86 million
• Optionable: Not Optionable
• Beta: 7.01